树突细胞效应机制和瘤免疫微环境透定义了TLR8调制和PD-1阻断
Daniel A Ruiz-Torres1,2,3,4, Jillian F Wise2,3,4,5,6, Brian Yinge Zhao1
1Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear, Boston, MA, United States.
Frontiers in immunology
|December 19, 2024
概括
结合类似收费受体8 (TLR8) 激素与PD-1 阻断,可提高头癌患者的先天免疫反应. 这种双重疗法增加了树突细胞和T细胞,有可能增强抗瘤免疫力.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 翻译医学是一种翻译医学.
背景情况:
- 收费类受体8 (TLR8) 激素和PD-1阻断的组合在癌症免疫治疗的临床前研究中显示出有前途.
- 然而,驱动这种组合在人类患者中有效性的精确机制,特别是在头部和部状细胞癌 (HNSCC) 中,仍然在很大程度上未被探索.
研究的目的:
- 在HNSCC患者中阐明TLR8激动和PD-1阻断的联合作用机制.
- 在手术前的临床试验中研究这种双重疗法诱导的免疫变化.
主要方法:
- 在HNSCC患者中进行了一项开放式的1b期临床试验 (NCT03906526).
- 在治疗前和治疗后进行匹配的瘤活检,使用单细胞RNA测序和多重染色进行分析.
- 数据与先前用抗PD-1单一治疗的队列进行了比较.
主要成果:
- 双重TLR8激素和抗PD-1阻断导致了先天免疫基因和细胞因子的显著上调.
- 观察到CLEC9A+树突细胞种群增加和CLEC7A/SYK表达升高.
- 在治疗后,在 CD8+ T 细胞附近发现成熟的树突细胞,细胞毒性 T 淋巴细胞密度增加,CXCL13+ CD8+ T 细胞种群扩大,以及响应者的第三级淋巴状结构 (TLS) 增强.
结论:
- 这项研究表明,将TLR8激动性与PD-1阻断相结合,可以增强先天性免疫激活,并促进HNSCC中的自适应性免疫反应.
- 这些发现为这种联合治疗的免疫调节作用提供了关键的见解,为优化癌症治疗策略铺平了道路.
相关概念视频
Tumor Immunotherapy
475
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
475
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
T Cell Activation and Clonal Selection
655
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
655
Cytotoxic T Cells-mediated Immune Response
844
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
844
T Cell Types and Functions
947
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
947


